Anti-interleukin-5/anti-interleukin-5 receptor α treatment improves self-reported work productivity in patients with severe eosinophilic asthma: a prospective cohort trial

Background Severe asthma affects the working life of millions of people worldwide. Interleukin (IL)-5/anti-interleukin-5 receptor α (IL-5Rα) antibodies are highly effective in reducing symptoms in patients with severe eosinophilic asthma. We analysed effects of anti-IL-5/anti-IL-5Rα treatment on sel...

Full description

Saved in:
Bibliographic Details
Main Authors: Lina Brinkmann, Jan Fuge, Tobias Welte, Hendrik Suhling, Nora Drick
Format: Article
Language:English
Published: European Respiratory Society 2024-11-01
Series:ERJ Open Research
Online Access:http://openres.ersjournals.com/content/10/6/00374-2024.full
Tags: Add Tag
No Tags, Be the first to tag this record!